The Global Cell Culture Media Bags Industry is poised for an unprecedented surge, with a projected valuation of US$ 3,541 million by 2033, up from US$ 1,308.7 million in 2023. This remarkable growth, underpinned by a steady 10.5% compound annual growth rate (CAGR), reflects the increasing demand for cell culture media bags in a range of industries.
In recent years, the demand for cell culture media bags has experienced significant growth, and this trend is anticipated to persist in the years to come. Several key factors drive this thriving market, including the surging popularity of single-use systems, the rising demand for biologics, continuous technological advancements, expanding investments in biotech research and development, and the growing applications in regenerative medicine.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12670
Key Takeaways
- 2D bag designs are expected to account for over half of the market value, owing to their high flexibility
- Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
- By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
- Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
- US will remain the largest market for cell culture media bags globally.
“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks FMI analyst.
Who is Winning?
Cell culture media bags manufacturers are focusing on developing solutions that address the key challenges such as recycling of multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.
- In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
- In August, 2015, Rim Bio partnered with Playmouth based Sentrol for sales and distribution of its single-use bio containers across the United States.
FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorious AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.
Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-12670
Key Segments:
Global Cell Culture Media Bags Industry by Bag Size:
- Very Small Bags (< 150 ml)
- Small Bags (151 – 500 ml)
- Medium Sized Bags (501 – 1000 ml)
- Large Bags (1001- 3000 ml)
- Very Large Bags (>3000 ml)
Global Cell Culture Media Bags Industry by Application:
- Storage
- Mixing
- Processing
- Gas Exchanges
- Heat Transfer
- Turbidity
- Flow Rate Monitoring
- Pressure
- Viscosity
Global Cell Culture Media Bags Industry by Host Cell:
- Mesenchymal Cells
- Plant Cells
- Insect Cells
- Bacteria Cells
- Yeast Cells
- Chinese Hamster Ovary
- Baby Hamster Kidney
Global Cell Culture Media Bags Industry by Bag Design:
- 2D Cell Culture Media Bags
- 3D Cell Culture Media Bags
Global Cell Culture Media Bags Industry by End Use:
- Life Science R&D
- Biopharmaceutical Manufacturers
Global Cell Culture Media Bags Industry by Region:
- North America Cell Culture Media Bags Market
- Latin America Cell Culture Media Bags Industry
- Europe Cell Culture Media Bags Industry
- East Asia Cell Culture Media Bags Industry
- South Asia & Pacific Cell Culture Media Bags Market
- Middle East & Africa (MEA) Cell Culture Media Bags Industry
Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/12670
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
